Exelixis (EXEL) Shares Outstanding (Diluted Average) (2010 - 2026)

Exelixis (EXEL) recorded quarterly Shares Outstanding (Diluted Average) of $267.3 million in Q2 2026, down 5.16% quarter-over-quarter from $281.9 million in Q1 2026, and down 7.24% on a YoY basis from $288.2 million in Q2 2025.

Exelixis (EXEL) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends

Exelixis' Shares Outstanding (Diluted Average) history runs 15 years deep, the most recent figure standing at $267.3 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Diluted Average) fell 7.24% year-over-year to $267.3 million; the TTM figure through Apr 2026 stood at $267.3 million (down 7.24% YoY), while the FY2026 annual figure was $281.9 million, down 4.82% from the prior year.
  • Shares Outstanding (Diluted Average) was $267.3 million for Q2 2026 at Exelixis, down from $281.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $326.8 million in Q2 2023 to a low of $267.3 million in Q2 2026.
  • Historically, Shares Outstanding (Diluted Average) has averaged $304.9 million across 5 years, with a median of $305.5 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) rose 0.92% in 2023, then dropped 10.11% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $324.6 million in 2022, then dropped by 0.95% to $321.5 million in 2023, then dropped by 9.33% to $291.5 million in 2024, then dropped by 4.44% to $278.5 million in 2025, then retreated by 4.03% to $267.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $267.3 million (Q2 2026), $281.9 million (Q1 2026), and $278.5 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 256.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - 92.44 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 267.32 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 267.32 Mn
Jan 2, 2026 281.86 Mn
Oct 3, 2025 278.54 Mn
Jul 4, 2025 284.39 Mn
Apr 4, 2025 288.18 Mn
Jan 3, 2025 296.13 Mn
Sep 27, 2024 291.48 Mn
Jun 28, 2024 293.97 Mn
Mar 29, 2024 305.53 Mn
Dec 29, 2023 321.46 Mn
Sep 29, 2023 324.28 Mn
Jun 30, 2023 326.79 Mn
Mar 31, 2023 326.28 Mn
Dec 30, 2022 324.56 Mn
Sep 30, 2022 324.42 Mn
Jul 1, 2022 324.10 Mn
Apr 1, 2022 323.29 Mn
Dec 31, 2021 322.36 Mn
Oct 1, 2021 322.08 Mn
Jul 2, 2021 322.11 Mn